Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. (Q36388536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Saurenmann RK

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Levin AV

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rose JB

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Parker S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rabinovitch T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Feldman BM

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Laxer RM

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Schneider R

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Silverman ED

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

1 reference

3 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

982-989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16461435%20AND%20SRC:MED&resulttype=core&format=json

Visual loss associated with pediatric uveitis in english primary and referral centers.

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Changing patterns in uveitis of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Management of uveitis in pediatric patients: special considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Special considerations in the evaluation and management of uveitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Cyclosporin A therapy in refractory non-infectious childhood uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Experience with cyclosporine in endogenous uveitis posterior

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Biologic agents for the treatment of juvenile rheumatoid arthritis: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Etanercept therapy in children with treatment-resistant uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Does etanercept induce uveitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Infliximab for juvenile idiopathic arthritis-associated uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030

Ocular complications of pediatric uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL030